- New alliance will crack down on adulterated products touting dietary supplement claims
- Watson seeks FDA approval for generic Welchol
- Mylan's generic arthritis drug receives FDA approval
- FDA limits amount of acetaminophen in prescription drugs
- FDA approves Novartis drug for high blood pressure treatment
PARSIPPANY, N.J. — The Food and Drug Administration has approved a drug for arthritis made by Watson Pharmaceuticals, Watson said Friday.
The drug maker announced the approval of nabumetone tablets in the 500-mg and 750-mg strength. The drug is used to treat signs and symptoms of rheumatoid arthritis and osteoarthritis.
Nabumetone had sales of $58 million during the 12-month period ended in April, according to IMS Health.